NCT00703833View on ClinicalTrials.gov

A Study of MK0777 Gel Extrusion Module (GEM) in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-019)

PHASE2CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

February 28, 2003

Study Completion Date

February 28, 2003

Conditions
Generalized Anxiety Disorder
Interventions
DRUG

MK0777

Days 1-3 3mg MK0777, Days 4-7 6 mg MK0777, Days 8-28 3, 6 or 9 mg MK0777

DRUG

Placebo (unspecified)

matching placebo

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00703833 - A Study of MK0777 Gel Extrusion Module (GEM) in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-019) | Biotech Hunter | Biotech Hunter